================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 4, 2004
MERCK & CO., INC.
(Exact name of registrant as specified in its charter)
New Jersey 1-3305 22-1109110
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
One Merck Drive
P.O. Box 100, Whitehouse Station, NJ 08889-0100
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (908) 423-1000
Not Applicable
(Former name or former address, if changed since last report)
================================================================================
Item 5. Other Events
On February 4, 2004, Merck & Co., Inc. entered into an underwriting agreement
(the "Underwriting Agreement") with Citigroup Global Markets Inc. and Morgan
Stanley & Co. Incorporated, for the sale of $350,000,000 2.50% Notes due
March 30, 2007.
The Underwriting Agreement is filed as Exhibit 1.1 to this Form 8-K.
Item 7. Financial Statements, Pro Forma Financial Statements, and Exhibits
(c) Exhibits
1.1 Underwriting Agreement, dated February 4, 2004, between
Merck & Co., Inc. and Citigroup Global Markets Inc. and
Morgan Stanley & Co. Incorporated.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
MERCK & CO., INC.
(Registrant)
February 10, 2004 /s/ Debra A. Bollwage
---------------------
DEBRA A. BOLLWAGE
Assistant Secretary
EXHIBIT INDEX
-------------
Exhibit
Number Description
------- ------------
1.1 Underwriting Agreement, dated February 4, 2004,
between Merck & Co. Inc. and Citigroup Global
Markets Inc. and Morgan Stanley & Co. Incorporated.